Gil Shaulsky to Receptors, N-Methyl-D-Aspartate
This is a "connection" page, showing publications Gil Shaulsky has written about Receptors, N-Methyl-D-Aspartate.
Connection Strength
1.079
-
Overlapping cortical malformations in patients with pathogenic variants in GRIN1 and GRIN2B. J Med Genet. 2023 02; 60(2):183-192.
Score: 0.181
-
Opportunities for Precision Treatment of GRIN2A and GRIN2B Gain-of-Function Variants in Triheteromeric N-Methyl-D-Aspartate Receptors. J Pharmacol Exp Ther. 2022 04; 381(1):54-66.
Score: 0.179
-
Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of N-Methyl-d-aspartate Receptors. ACS Chem Neurosci. 2021 01 06; 12(1):79-98.
Score: 0.165
-
Negative allosteric modulation of GluN1/GluN3 NMDA receptors. Neuropharmacology. 2020 10 01; 176:108117.
Score: 0.158
-
De novo mutations in GRIN1 cause extensive bilateral polymicrogyria. Brain. 2018 03 01; 141(3):698-712.
Score: 0.136
-
The Bioactive Protein-Ligand Conformation of GluN2C-Selective Positive Allosteric Modulators Bound to the NMDA Receptor. Mol Pharmacol. 2018 02; 93(2):141-156.
Score: 0.134
-
A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia. PLoS One. 2017; 12(2):e0170818.
Score: 0.126